rethinkTHC Search
Menu
Study breakdown

How Alcohol Changes Your Endocannabinoid Levels and What That Means for How Drunk You Feel

Randomized Controlled TrialModerate evidence
The takeaway

Alcohol decreased 2-AG endocannabinoid levels in social drinkers, and this drop was linked to less drug liking and fewer feelings of friendliness.

Addiction researchers, neuroscientists studying reward systems, and anyone interested in how alcohol and the endocannabinoid system interact.

Alcohol lowered 2-AG; bigger drop = less liking

What the researchers found

Acute alcohol consumption decreased 2-AG concentrations compared to placebo. A drop in 2-AG was associated with less drug "liking" and fewer feelings of "friendliness." Under placebo conditions, rising 2-AG was associated with maintained feelings of "stimulation." Alcohol did not significantly affect anandamide levels.

Why it matters

This is the first evidence that endocannabinoids may explain individual differences in how people experience alcohol's rewarding effects. People whose 2-AG drops more after drinking may find alcohol less pleasurable, potentially influencing their drinking patterns.

The numbers in context

28 participants, aged 20-35. Alcohol dose: 0.6 g/kg (20% reduction for women). 2-AG decreased with alcohol vs placebo. Lower 2-AG correlated with less "liking" and "friendliness." Anandamide was not significantly affected.

How the study worked

Within-subjects, single-blind, placebo-controlled alcohol challenge study with 28 healthy social drinkers aged 20-35. Alcohol (0.6 g/kg) and placebo sessions were counterbalanced. Endocannabinoids were measured from blood plasma; subjective effects via BAES, DEQ, and POMS.

What this study cannot tell us

Small sample (28 participants). Single acute alcohol dose does not capture chronic drinking effects. Peripheral blood endocannabinoid levels may not perfectly reflect brain levels. Social drinkers only, not people with alcohol use disorder.

How to read the evidence

Well-designed placebo-controlled crossover study, but small sample size limits generalizability.

When this study was published

2026 RCT.

The bigger picture

Understanding how the endocannabinoid system mediates alcohol's rewarding effects could lead to new treatments for alcohol use disorder. If 2-AG levels modulate how pleasurable alcohol feels, targeting this system could reduce alcohol's appeal.

Questions still open

  • Do people with alcohol use disorder show different endocannabinoid responses to drinking? Could drugs targeting the 2-AG pathway reduce alcohol's rewarding effects?

Common questions

How are alcohol and the endocannabinoid system connected?
This study found alcohol decreases blood levels of the endocannabinoid 2-AG. How much 2-AG changes appears to influence how pleasurable a person finds alcohol.
Could this help treat alcoholism?
Potentially. If the endocannabinoid system mediates how rewarding alcohol feels, drugs targeting this system might reduce the motivation to drink. But this needs much more research.

Read the original research

Effects of acute alcohol administration on endocannabinoids and relation to subjective effects.

Psychopharmacology, 243(2), 401-411

Citation

Petrie, Gavin N; Mazurka, Raegan; Paul, Elisabeth R; Stensson, Niclas; Ghafouri, Bijar; Hill, Matthew N; Heilig, Markus; Mayo, Leah M. (2026). Effects of acute alcohol administration on endocannabinoids and relation to subjective effects.. Psychopharmacology, 243(2), 401-411. https://doi.org/10.1007/s00213-025-06843-6

Explore the wider topic